Newswire (Published: Monday, February 18, 2019, Received: Tuesday, February 19, 2019, 5:35:15 PM CST)
Word Count: 535
2019 FEB 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting originating in Manila, Philippines, by NewsRx journalists, research stated, “Patients of proton beam therapy (PBT) for prostate cancer had been continuously growing in number due to its promising characteristics of high dose distribution in the tumor target and a sharp distal fall-off. Considering the large number of proton beam facilities in Japan, the further increase of patients undergoing this treatment is due to the emendations by Japanese National Health Insurance (NHI) and the development of medical equipment and technology, it is necessary to know what kind of research and advancements has been done on proton therapy for prostate cancer in the country.”
Financial supporters for this research include Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Japan Society for the Promotion of Science (JSPS) KAKENHI.
The news reporters obtained a quote from the research from the University of Santo Tomas, “For these reasons, this literature review was conducted. The aim of this review is to identify and discuss research studies of proton beam therapy for prostate cancer in Japan. These include observational, interventional, and secondary data analysis of published articles. A literature review on published works related to proton beam therapy for prostate cancer in Japan was conducted using articles that were gathered in the PubMed database of June 2018. We went through abstracts and manuscripts written in English with the keywords proton beam therapy’, prostate cancer’, and Japan’. A total of 23 articles were included. Fourteen articles were observational studies, most of which focused on the adverse effects of Proton Beam Therapy (PBT). Seven articles were interventional studies related on treatment planning, equipment parts, as well as target positioning. Two were secondary data analysis. The included studies were published in 13 different journals by different institutions using various equipment. Despite the favorable results of proton beam therapy, future research should include more patients and longer follow-up schedules to clarify the definitive role of PBT, yet, up to recent retrospective studies, included in this paper, concluded that PBT can be a suitable treatment option for localized prostate cancer.”
According to the news reporters, the research concluded: “In addition, interventional studies were conducted by several institutions to further embellish proton therapy.”
For more information on this research see: A Literature Review of Proton Beam Therapy for Prostate Cancer in Japan. Journal of Clinical Medicine, 2019;8(1):48. Journal of Clinical Medicine can be contacted at: Mdpi, St Alban-Anlage 66, Ch-4052 Basel, Switzerland.
Our news correspondents report that additional information may be obtained by contacting R.M. Hoshina, Univ Santo Tomas, Fac Med & Surg, Manila 1002, Philippines. Additional authors for this research include T. Matsuura, K. Umegaki and S. Shimizu.
The direct object identifier (DOI) for that additional information is: https://doi.org/10.3390/jcm8010048. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
(Our reports deliver fact-based news of research and discoveries from around the world.)
University of Santo Tomas
Science and Technology
Entertainment and the Arts
Health and Wellness
Medical Conditions and Diseases
Men's Health Issues
Treatments and Therapies